A Homozygous MRPL24 Mutation Causes a Complex Movement Disorder and Affects the Mitoribosome Assembly T
Total Page:16
File Type:pdf, Size:1020Kb
Neurobiology of Disease 141 (2020) 104880 Contents lists available at ScienceDirect Neurobiology of Disease journal homepage: www.elsevier.com/locate/ynbdi A homozygous MRPL24 mutation causes a complex movement disorder and affects the mitoribosome assembly T Michela Di Nottiaa,1, Maria Marcheseb,1, Daniela Verrignia, Christian Daniel Muttic, Alessandra Torracoa, Romina Olivad, Erika Fernandez-Vizarrac, Federica Moranib, Giulia Trania, Teresa Rizzaa, Daniele Ghezzie,f, Anna Ardissoneg,h, Claudia Nestib, Gessica Vascoi, Massimo Zevianic, Michal Minczukc, Enrico Bertinia, Filippo Maria Santorellib,2, ⁎ Rosalba Carrozzoa, ,2 a Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy b Molecular Medicine & Neurogenetics, IRCCS Fondazione Stella Maris, Pisa, Italy c MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK d Department of Sciences and Technologies, University Parthenope of Naples, Naples, Italy e Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy f Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy g Child Neurology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy h Department of Molecular and Translational Medicine DIMET, University of Milan-Bicocca, Milan, Italy i Department of Neurosciences, IRCCS Bambino Gesù Children Hospital, Rome, Italy ARTICLE INFO ABSTRACT Keywords: Mitochondrial ribosomal protein large 24 (MRPL24) is 1 of the 82 protein components of mitochondrial ribo- Mitochondrial disorders somes, playing an essential role in the mitochondrial translation process. Movement disorder We report here on a baby girl with cerebellar atrophy, choreoathetosis of limbs and face, intellectual dis- MRPL24 ability and a combined defect of complexes I and IV in muscle biopsy, caused by a homozygous missense mu- Mitoribosomes tation identified in MRPL24. The variant predicts a Leu91Pro substitution at an evolutionarily conserved site. Mitochondrial protein synthesis Using human mutant cells and the zebrafish model, we demonstrated the pathological role of the identified Zebrafish fi fi Molecular modeling variant. In fact, in broblasts we observed a signi cant reduction of MRPL24 protein and of mitochondrial Protein interactions respiratory chain complex I and IV subunits, as well a markedly reduced synthesis of the mtDNA-encoded peptides. In zebrafish we demonstrated that the orthologue gene is expressed in metabolically active tissues, and that gene knockdown induced locomotion impairment, structural defects and low ATP production. The motor phenotype was complemented by human WT but not mutant cRNA. Moreover, sucrose density gradient frac- tionation showed perturbed assembly of large subunit mitoribosomal proteins, suggesting that the mutation leads to a conformational change in MRPL24, which is expected to cause an aberrant interaction of the protein with other components of the 39S mitoribosomal subunit. 1. Introduction The human MRP gene family comprises 30 genes encoding for the small mitochondrial ribosomal subunit and 52 genes for the large subunit, all Mammalian Mitochondrial Ribosomal Proteins (MRPs) are encoded of which are nuclear encoded (Gopisetty and Thangarajan, 2016). by nuclear genes and are required for the translation of the 13 mtDNA- Building a mitoribosome is a difficult logistical task comparable to the encoded proteins within the mitochondrion. Mitochondrial ribosomes complexity of assembling the entire respiratory chain, since the bio- (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. genesis of mitoribosomes depends on the coordinated synthesis of ⁎ Corresponding author at: Unit of Muscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Viale di San Paolo 15, 00146 Rome, Italy. E-mail address: [email protected] (R. Carrozzo). 1 These authors contributed equally to this work. 2 These authors contributed equally as senior authors. https://doi.org/10.1016/j.nbd.2020.104880 Received 12 July 2019; Received in revised form 4 March 2020 Available online 25 April 2020 0969-9961/ © 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/). M. Di Nottia, et al. Neurobiology of Disease 141 (2020) 104880 MRPs, which must be translated on cytoplasmic ribosomes and im- glutamine supplemented with sodium pyruvate (0.11 g/L) 10% fetal ported into mitochondria (Bogenhagen et al., 2018). Mitoribosomes are bovine serum, and 50 μg/mL uridine. Complex V activity (in the di- essential for the synthesis of the oxidative phosphorylation machinery. rection of ATP synthesis) was measured in fibroblast mitochondria, It has indeed been proposed that the absence or deficiency of MRPs may using reported spectrophotometric methods (Rizza et al., 2009). cause primary oxidative phosphorylation disorders (O'Brien et al., Oxygen consumption rate (OCR) was measured in adherent fibroblasts 2000). The consequences of mutations in MRP genes are expected to with an XFe24 Extracellular Flux Analyzer (Seahorse Bioscience,Agi- reproduce the clinical heterogeneity of oxidative phosphorylation dis- lent, Santa Clara, CA), as described in Tolomeo et al., 2019. Western orders, ranging from lethality to less severe phenotypes associated with blotting using monoclonal antibodies complex I – NDUFA9 and marginally impaired energy metabolism, as mutations that do not fully NDUFS1; complex II – SDHA; complex III – UQCRC2; complex IV – inactivate the protein function may have intermediate effects (O'Brien COXIV; complex V – ATP5A1, and porin (VDAC) was performed using et al., 2005). In addition, mutations in MRP genes could cause tissue- precast 4–12% denaturating gels (Bolt™ 4–12% Bis-Tris Plus Gels, specific disorders (Spirina et al., 2000). The crucial role of mitoribo- Thermo Fisher Scientific, Waltham, MA USA) as reported (Torraco somes in OXPHOS biogenesis underlines the involvement of MRPs in a et al., 2018). All monoclonal antibodies were from MitoSciences (Eu- number of conditions associated with mitochondrial dysfunction (Bieri gene, OR, USA). The polyclonal ab-MRPL24 was from Abcam (Cam- et al., 2018). The importance of the proper composition and structure of bridge, UK). mitoribosomes for human health has led to their recent structural Analysis of mitochondrial protein synthesis was performed as pre- characterization, which provided detailed insight in the protein-rich viously described (Chomyn, 1996; Fernández-Silva et al., 2007). Im- mammalian mitoribosome (Amunts et al., 2015; Greber et al., 2015), mortalized fibroblasts at 70% confluence were labeled for 1 h with and a structure-based kinetic model for its assembly (Bogenhagen et al., [35S]-L-methionine in the presence of 100 μg/mL emetine, an inhibitor 2018). Finally, very recently, dysfunction of these proteins has been of cytosolic protein synthesis. Samples were kept at −80 °C until use. demonstrated to play a role not only in the primary mitochondrial re- Twenty μg of total cellular protein were loaded on a Novex™ 18% Tris- spiratory chain activity deficiencies, but also in other conditions, such Glycine precast SDS polyacrylamide gel (Invitrogen). The gel was then as cancer, impaired development, neurodegeneration, cardiovascular fixed and dried, and the mitochondrial translation products were vi- failure, obesity and inflammatory disorders (Gopisetty and sualized using a Storage Phosphor Screen and a Typhoon 9410 Variable Thangarajan, 2016). Mode Imager (GE Healthcare). Mitochondrial ribosomal protein large 24 (MRPL24) is one of the For all experiments, age-matched controls were used. protein components of the large (39S) subunit of mitochondrial ribo- somes (Kenmochi et al., 2001). Herein, we report on the first case with 2.4. Model building and in silico analysis mutation in MRPL24 and provide a comprehensive investigation of its clinical, biochemical and structural consequences. We demonstrated For the analysis of the MRPL24 structure in the context of human the pathological role of the identified variant using human mutant cells. mitoribosome, the structure of the entire mitoribosome solved by Moreover, we evaluated the consequence of a dysfunctional Mrlp24 in electron microscopy at a resolution of 3.5 Å was used (PDB ID: 3j9m, the developing zebrafish embryos, in order to determine the impact on Amunts et al., 2015). As the coordinates of the MRPL24 159–168 early stages of development. fragment are missing from this structure, they were comparatively modeled with Modeller9v17 (Sali and Blundell, 1993), using as tem- 2. Material and methods plate the structure of the 89% sequence identical homologous protein from Sus scrofa (PDB ID: 4v19, Greber et al., 2014a, 2014b). To simu- 2.1. Standard protocol approvals, registrations, and patient consent late the structural effect of the Leu91Pro mutation, Leu91 was mutated to Pro and its phi (ϕ) dihedral angle was set at −63° with PyMol The study was approved by the Ethical Committees of the Bambino (DeLano, 2002): 63° is indeed the ϕ value typically assumed by prolines Gesù Children Hospital, Rome, Italy, in agreement with the Declaration in proteins (with variations within ± 15°, MacArthur and Thornton, of Helsinki. Informed consent was signed by the parents of the patient. 1991). The analysis of the interface areas and of the inter-residue contacts